Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases (Q38848481)

7 September 2017

0 references

1 reference

title

Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases (English)

1 reference

7 September 2017

0 references

1 reference

4

Maciej Banach

1 reference

7 September 2017

5

Amirhossein Sahebkar

1 reference

7 September 2017

Amir Abbas Momtazi

1

0 references

Pamela Maffioli

object named as

Pamela Maffioli

series ordinal

3

0 references

Giuseppe Derosa

object named as

Giuseppe Derosa

series ordinal

2

0 references

language of work or name

1 reference

30 May 2016

1 reference

Molecular Diagnosis and Therapy

7 September 2017

1 reference

7 September 2017

20

1 reference

7 September 2017

4

1 reference

7 September 2017

335-345

1 reference

https://scigraph.springernature.com/pub.10.1007/s40291-016-0202-7

7 September 2017

0 references

cites work

Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Potential anticancer activity of turmeric (Curcuma longa).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Cytotoxic activities of phytochemicals from Ferula species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Curcumin retunes cholesterol transport homeostasis and inflammation response in M1 macrophage to prevent atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Lipid-lowering effects of curcumin in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Effect of curcumin on the expression of LDL receptor in mouse macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Study of curcumin immunomodulatory effects on reactive astrocyte cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Immunomodulatory effects of nanocurcumin in arsenic-exposed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Curcumin downregulates human tumor necrosis factor-α levels: A systematic review and meta-analysis ofrandomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Antioxidant activity of curcumin and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Curcumin improves synaptic plasticity impairment induced by HIV-1gp120 V3 loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Curcumin attenuates brain edema in mice with intracerebral hemorrhage through inhibition of AQP4 and AQP9 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Oral curcumin has anti-arthritic efficacy through somatostatin generation via cAMP/PKA and Ca(2+)/CaMKII signaling pathways in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Curcumin potentiates the anti-arthritic effect of prednisolone in Freund's complete adjuvant-induced arthritic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Analgesic Efficacy and Safety of Curcuminoids in Clinical Practice: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Fungicidal property of Curcuma longa L. rhizome-derived curcumin against phytopathogenic fungi in a greenhouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Curcumin for malaria therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Curcumin as a regulator of epigenetic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Epigenetic drivers and genetic passengers on the road to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Roles of microRNA on cancer cell metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

A microRNA in a multiple-turnover RNAi enzyme complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

MicroRNAs in common human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

MicroRNAs in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

MicroRNAs in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Cellular and molecular mechanisms of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation--a novel mechanism suppressing liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

EUKARYOTIC CYTOSINE METHYLTRANSFERASES

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

GFAP promoter-driven RNA interference on TGF-β1 to treat liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Antidepressant activity of curcumin: involvement of serotonin and dopamine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Curcumin-induced upregulation of the anti-tau cochaperone BAG2 in primary rat cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Optimized curcumin formulations for the treatment of Alzheimer's disease: A patent evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Autophagic activation: A key piece of the puzzle for the curcumin-associated cognitive enhancement?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Pathways towards and away from Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Neurotoxicity induces cleavage of p35 to p25 by calpain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

The cochaperone BAG2 sweeps paired helical filament- insoluble tau from the microtubule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Up-regulation of NF-kB-sensitive miRNA-125b and miRNA-146a in metal sulfate-stressed human astroglial (HAG) primary cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Standardized curcuminoid extract (Curcuma longa l.) decreases gene expression related to inflammation and interacts with associated microRNAs in human umbilical vein endothelial cells (HUVEC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Valproic acid potentiates curcumin-mediated neuroprotection in lipopolysaccharide induced rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Clinical development of curcumin in neurodegenerative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Curcumin, a potential therapeutic candidate for retinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Diabetic nephropathy: diagnosis, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Mechanisms of diabetic nephropathy: role of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Mechanical forces and TGFbeta1 reduce podocyte adhesion through alpha3beta1 integrin downregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

The podocyte's response to stress: the enigma of foot process effacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Lack of {alpha}8-integrin aggravates podocyte injury in experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Roles for microRNAs in the regulation of cell adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Changes in microRNAs associated with podocytic adhesion damage under mechanical stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

The Attenuation of Pain Behavior and Serum COX-2 Concentration by Curcumin in a Rat Model of Neuropathic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Modification of kidney barrier function by the urokinase receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Genistein modulates NF-κB-associated renal inflammation, fibrosis and podocyte abnormalities in fructose-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Pterostilbene and allopurinol reduce fructose-induced podocyte oxidative stress and inflammation via microRNA-377.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

The inducible deletion of Drosha and microRNAs in mature podocytes results in a collapsing glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Curcumin protects against fructose-induced podocyte insulin signaling impairment through upregulation of miR-206.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Modulation of miRNA expression by dietary polyphenols in apoE deficient mice: a new mechanism of the action of polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-016-0202-7

Differential gene expression of livers from ApoE deficient mice

21 January 2018

1 reference

12 December 2020

Curcuminoids for the management of hypertriglyceridaemia

1 reference

12 December 2020

Potentials of curcumin as an antidepressant.

1 reference

12 December 2020

Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats

1 reference

12 December 2020

Curcumin--a natural herb with anti-HIV activity

1 reference

12 December 2020

Curcumin reorganizes miRNA expression in a mouse model of liver fibrosis.

1 reference

12 December 2020

Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD)

1 reference

12 December 2020

Global microRNA expression profiling: curcumin (diferuloylmethane) alters oxidative stress-responsive microRNAs in human ARPE-19 cells

1 reference

12 December 2020

Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue

1 reference

12 December 2020

Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial.

1 reference

12 December 2020

Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial

1 reference

12 December 2020

Curcumin ameliorates Podocytic adhesive capacity damage under mechanical stress by inhibiting miR-124 expression

1 reference

12 December 2020

Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen.

1 reference

12 December 2020

Molecular mechanisms for curcumin benefits against ischemic injury

1 reference

12 December 2020

Proniosomal formulation of curcumin having anti-inflammatory and anti-arthritic activity in different experimental animal models

1 reference

12 December 2020

Curcumin attenuates diet-induced hypercholesterolemia in rats.

1 reference

12 December 2020

Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research

1 reference

12 December 2020

Short-term Curcuminoid Supplementation for Chronic Pulmonary Complications due to Sulfur Mustard Intoxication: Positive Results of a Randomized Double-blind Placebo-controlled Trial

1 reference

12 December 2020

Clinical development plan: curcumin

1 reference

12 December 2020

Mitigation of Systemic Oxidative Stress by Curcuminoids in Osteoarthritis: Results of a Randomized Controlled Trial

1 reference

12 December 2020

Enhancement of wound healing by curcumin in animals

1 reference

12 December 2020

Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture

1 reference

12 December 2020

Curcumin attenuates adhesion molecules and matrix metalloproteinase expression in hypercholesterolemic rabbits

1 reference

12 December 2020

Curcumin Protects Neurons from Glutamate-Induced Excitotoxicity by Membrane Anchored AKAP79-PKA Interaction Network

1 reference

12 December 2020

Low-density lipoprotein is a potential target for curcumin: novel mechanistic insights

1 reference

12 December 2020

An evaluation of progressive amyloidogenic and pro-inflammatory change in the primary visual cortex and retina in Alzheimer's disease (AD).

1 reference

12 December 2020

10.1007/S40291-016-0202-7

Identifiers

DOI

1 reference

PubMed ID

27241179

Dimensions Publication ID

7 September 2017

0 references

1 reference

PubMed ID

27241179